Fig. 2From: Is monitoring of plasma 5-fluorouracil levels in metastatic / advanced colorectal cancer clinically effective? A systematic reviewThe incidence of various grades of adverse events in the BSA and PKA arms of Gamelin et al. [38]. The graph shows the proportion (95 % CI) of patients experiencing adverse events in the BSA and PKA arms during treatment with a 5-fluorouracil + folinic acid (FA) regimen in which 5-fluorouracil is infused over 8 hBack to article page